Geoff Brooke
Gründer bei ACTINOGEN MEDICAL LIMITED
Vermögen: 101 156 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Geoff Brooke
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Other | 32 | |
ChemGenex Pharmaceuticals Pty Ltd.
 ChemGenex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology ChemGenex Pharmaceuticals Pty Ltd. develops pharmaceutical products. It develops small molecules with new mechanisms of action to treat malignancies with significant unmet medical needs. The firm also develops personalized oncology, obesity and diabetes medicines. The company was founded in September 1958 and is headquartered in Geelong, Australia.
15
| Extinct | Pharmaceuticals: Major | 15 |
| Public Company | Pharmaceuticals: Major | 14 | |
CoDa Therapeutics (NZ) Ltd.
 CoDa Therapeutics (NZ) Ltd. Pharmaceuticals: MajorHealth Technology CoDa Therapeutics (NZ) Ltd. develops and markets biopharmaceutical products. The company was founded by David Becker, Colin Green, Bradford J, Duft, and Howard E. Greene and on December 9, 2003 and is headquartered in Auckland, New Zealand.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
| Public Company | Biotechnology | 10 | |
OcuNexus Therapeutics, Inc.
 OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Victorian WorkCover Authority
5
| Government | General Government | 5 |
Cerylid Biosciences Ltd.
 Cerylid Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Cerylid Biosciences Ltd. is an Australian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Richmond, Australia.
2
| Private Company | Pharmaceuticals: Major | 2 |
Prevatex Pty Ltd.
 Prevatex Pty Ltd. BiotechnologyHealth Technology Prevatex Pty Ltd. is an Australian company that focuses on restoring optimal gut health. The company is based in Geelong West, Australia. The company address the issue of the loss of important gut microbes due to changes in our modern lifestyle, such as bleaching of fresh foods, antibiotic use, and stress. The company was founded by James A. Campbell and Gregory Collier.
2
| Holding Company | Biotechnology | 2 |
ChemGenex Pharmaceuticals, Inc.
 ChemGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ChemGenex Pharmaceuticals, Inc. manufactures and develops pharmaceuticals. It develops novel protein, antibody, & small molecule therapeutics in the areas of oncology, obesity, diabetes, and central nervous system disorders. The company is a subsidiary of Chemgenex Pharmaceuticals Ltd. It was founded in 2004 and is headquartered in Menlo Park, CA.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Geoff Brooke
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree | |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| WESTERN YILGARN NL | Steel | Director/Board Member Director/Board Member Chairman Director of Finance/CFO Corporate Secretary General Counsel | |
| RED RIVER RESOURCES | Other Metals/Minerals | Chairman Director/Board Member Director of Finance/CFO Director/Board Member Corporate Secretary | |
Transport Accident Commission
 Transport Accident Commission Life/Health InsuranceFinance Transport Accident Commission provides compensation to motor vehicle accident victims. It campaigns to reduce the incidence of road trauma through accident prevention programs. The company was founded in 1987 and is headquartered in Geelong, Australia. | Life/Health Insurance | Chairman Director/Board Member Chief Operating Officer Director/Board Member | |
| The University of Western Australia | College/University | Masters Business Admin Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| The Institute of Chartered Accountants in Australia | Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
| PATERSON RESOURCES LTD | Precious Metals | Chairman Director/Board Member Director of Finance/CFO Corporate Secretary | |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Investment Managers | Chief Investment Officer Private Equity Investor Private Equity Investor | |
| RESPIRI LIMITED | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
| Financial Services Institute of Australasia | College/University | President Corporate Officer/Principal Graduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
| RACE ONCOLOGY LIMITED | Pharmaceuticals: Major | Corporate Secretary Director/Board Member Chairman | |
| MESOBLAST LIMITED | Biotechnology | Director/Board Member Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| DIMERIX LIMITED | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
InflammX Therapeutics, Inc.
 InflammX Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services InflammX Therapeutics, Inc. is a biopharmaceutical company that focuses on targeting the NLRP3 inflammasome pathway of inflammation. The private company is based in Tampa, FL. The company has identified the key disease-related upstream trigger for inflammasome activation and its therapeutics target this trigger. Its lead product, Xiflam™, is set to enter phase 2b clinical trials in the fourth quarter of 2022. In addition, InflammX has a follow-on pre-clinical peptide program that also targets the dysregulated NLRP3 inflammasome, which will be developed following additional funding being raised. The company was founded by Colin Richard Green, and the CEO is Brian Levy. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO Founder | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Generic Medicines Industry Association Pty Ltd.
 Generic Medicines Industry Association Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Generic Medicines Industry Association Pty Ltd. operates as a representative body of generic and biosimilar medicine suppliers in Australia. The company was founded on February 23, 2001 and is headquartered in Deakin West, Australia. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
| IDT AUSTRALIA LIMITED | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| NATIONAL AUSTRALIA BANK LIMITED | Major Banks | Corporate Officer/Principal General Counsel | |
| The University of Sydney | College/University | Graduate Degree Doctorate Degree | |
| Auckland University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Royal Pharmaceutical Society of Great Britain
 Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| RAKOVINA THERAPEUTICS INC. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| University of London | College/University | Undergraduate Degree Doctorate Degree | |
GBS Venture Partners Pty Ltd.
 GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partners Pty Ltd (GBS Venture Partners) is a venture capital firm founded in 1996 by Helen Brigitte Smith and Geoff E.D Brooke. The firm is headquartered in Melbourne. | Investment Managers | Investment Committee Member Private Equity Investor | |
| Mirvac Victoria Pty Ltd. | Chairman Director/Board Member | ||
| Deakin University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| TBG DIAGNOSTICS LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Macquarie University | College/University | Graduate Degree Masters Business Admin | |
| Emergency Services Telecommunications Authority | General Government | Chairman Director/Board Member | |
| MIRVAC INDUSTRIAL TRUST | Real Estate Investment Trusts | Chairman Director/Board Member | |
PolyBatics Ltd.
 PolyBatics Ltd. Miscellaneous Commercial ServicesCommercial Services PolyBatics Ltd. engages in the design, development, manufacturing and marketing of bionanoparticles. Its products include Assign-bTB, PolyZyme-CALB, PolyBind-Z and PolyBind-G. The firm harnesses the natural power of cells to create natural polymer particles, or biobeads, covered with proteins engineered to perform specific functions. The comapny was founded by Tracy Thompson and Bernd H. A. Rehm on January 9, 2009 and is headquartered in Palmerston North, New Zealand. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ORTHOCELL LIMITED | Medical Specialties | Chairman Corporate Secretary | |
NovaMedica LLC
 NovaMedica LLC Pharmaceuticals: MajorHealth Technology NovaMedica LLC operates as a pharmaceutical company. Its portfolio includes gastroenterology, ophthalmology, and neurology. The company was founded in 2012 and is headquartered in Moscow, Russian Federation. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman | |
RMI Partners OOO
 RMI Partners OOO Investment ManagersFinance RusnanoMedInvest (RMI) is a subsidiary of RUSNANO, a 100 percent Russian state-owned company whose mission is to develop the Russian nanotechnology industry through co investment in nanotechnology projects with substantial economic potential or social benefit. RMI was founded in 2012 headquartered in Russian. The firm to realize advanced projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia. | Investment Managers | Private Equity Investor Director/Board Member | |
Hatchtech Pty Ltd.
 Hatchtech Pty Ltd. Pharmaceuticals: MajorHealth Technology Hatchtech Pty Ltd. operates as pharmaceutical product company. It offers Xeglyze lotion that is head lice treatment. The company was founded by Vernon Morrison Bowles in 2001 and is headquartered in in Melbourne, Australia. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| IMMURON LIMITED | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Telstra Corp. Ltd.
 Telstra Corp. Ltd. Specialty TelecommunicationsCommunications Telstra Corp. Ltd. engages in the provision of telecommunications and information services for domestic and international customers. It operates through the following segments: Telstra Consumer and Small Business, Telstra Enterprise, Networks and IT, Telstra InfraCo, and All Others. The Telstra Consumer and Small Business segment comprises of telecommunication products, services, and solutions across mobiles, fixed and mobile broadband, telephony and play TV/IPTV, and digital content to consumer and small business customers in Australia. The Telstra Enterprise segment sells and contracts management for medium to large businesses, and government customers globally. The Networks and IT segment is responsible for the overall planning, design, engineering architecture, and construction of Telstra networks, technology, and information technology solutions. The Telstra InfraCo segment provides a range of telecommunication products and services delivered over Telstra networks and associated support systems to other carriers, carriage service providers, and internet service providers. The All Other segments include certain items of income and expense relating to multiple reportable segments that are recorded by its corporate areas. The company was founded in 1901 and is headquartered in Melbourne, Australia. | Specialty Telecommunications | Director/Board Member General Counsel | |
| RMIT University | College/University | Undergraduate Degree Masters Business Admin | |
| RESONANCE HEALTH LIMITED | Medical/Nursing Services | Director/Board Member Chairman | |
| SYNTARA LIMITED | Pharmaceuticals: Major | Chairman Director/Board Member | |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Pharmaceuticals: Major | Director/Board Member Founder |
Statistik
International
| Australien | 33 |
| Vereinigte Staaten | 11 |
| Neuseeland | 3 |
| Vereinigtes Königreich | 3 |
| Russland | 3 |
Sektoral
| Health Technology | 20 |
| Consumer Services | 11 |
| Finance | 8 |
| Commercial Services | 6 |
| Non-Energy Minerals | 5 |
Operativ
| Director/Board Member | 480 |
| Corporate Officer/Principal | 200 |
| Chairman | 116 |
| Independent Dir/Board Member | 114 |
| Corporate Secretary | 81 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Blair | 48 |
| Daniel Janney | 47 |
| Elana Rubin | 36 |
| Julie Cherrington | 32 |
| Elmar Schnee | 31 |
| Peter Webse | 31 |
| Paul Wotton | 27 |
| J. Buchi | 26 |
| Stewart Washer | 26 |
| Malcolm McComas | 23 |
| Malcolm James | 22 |
| Ross Dobinson | 21 |
| Anton Uvarov | 20 |
| Ted Greene | 20 |
| Jason Loveridge | 20 |
- Börse
- Insiders
- Geoff Brooke
- Unternehmensverbindungen
